Is aTyr Pharma, Inc. overvalued?

aTyr Pharma, Inc. (ATYR) — key valuation metrics and fundamentals.

No verdict

Price

$0.56

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$54.8M

Dividend yield

0.0%

Return on equity

-95.6%

Sector

Healthcare

Fair value compares ATYR's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.

Related stocks